Connor, Clark & Lunn Investment Management Ltd. Madrigal Pharmaceuticals, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

  • $18.8 Billion
  • Q3 2024

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 72,083 shares of MDGL stock, worth $25 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
72,083
Previous 83,062 13.22%
Holding current value
$25 Million
Previous $23.3 Million 34.26%
% of portfolio
0.08%
Previous 0.11%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$212.22 - $292.96 $2.33 Million - $3.22 Million
-10,979 Reduced 13.22%
72,083 $15.3 Million
Q2 2024

Aug 09, 2024
SELL
$193.33 - $291.99 $2.04 Million - $3.08 Million
-10,535 Reduced 11.26%
83,062 $23.3 Million
Q1 2024

May 09, 2024
BUY
$171.37 - $283.23 $6.77 Million - $11.2 Million
39,490 Added 72.99%
93,597 $25 Million
Q4 2023

Feb 09, 2024
BUY
$120.4 - $237.13 $291,488 - $574,091
2,421 Added 4.68%
54,107 $12.5 Million
Q3 2023

Nov 13, 2023
SELL
$146.04 - $225.78 $2.06 Million - $3.18 Million
-14,075 Reduced 21.4%
51,686 $7.55 Million
Q2 2023

Aug 10, 2023
SELL
$203.88 - $312.0 $591,863 - $905,736
-2,903 Reduced 4.23%
65,761 $15.2 Million
Q1 2023

May 09, 2023
BUY
$231.06 - $307.08 $1.91 Million - $2.54 Million
8,257 Added 13.67%
68,664 $16.6 Million
Q4 2022

Feb 10, 2023
BUY
$58.39 - $296.54 $2.07 Million - $10.5 Million
35,418 Added 141.73%
60,407 $17.5 Million
Q3 2022

Nov 10, 2022
BUY
$60.57 - $79.51 $1.11 Million - $1.45 Million
18,264 Added 271.58%
24,989 $1.62 Million
Q2 2022

Aug 05, 2022
BUY
$58.04 - $100.2 $195,943 - $338,275
3,376 Added 100.81%
6,725 $481,000
Q1 2022

May 12, 2022
SELL
$55.89 - $101.89 $61,255 - $111,671
-1,096 Reduced 24.66%
3,349 $329,000
Q4 2021

Feb 10, 2022
BUY
$72.34 - $95.09 $135,348 - $177,913
1,871 Added 72.69%
4,445 $377,000
Q3 2021

Nov 12, 2021
BUY
$78.35 - $105.02 $201,672 - $270,321
2,574 New
2,574 $205,000
Q1 2019

May 08, 2019
SELL
$103.48 - $143.84 $688,142 - $956,536
-6,650 Closed
0 $0
Q4 2018

Feb 12, 2019
SELL
$94.77 - $215.54 $170,586 - $387,972
-1,800 Reduced 21.3%
6,650 $750,000
Q3 2018

Nov 13, 2018
BUY
$207.3 - $300.31 $1.75 Million - $2.54 Million
8,450 New
8,450 $1.81 Million

Others Institutions Holding MDGL

# of Institutions
296
Shares Held
22M
Call Options Held
819K
Put Options Held
640K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.94B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email